News
Lindo Awarded $2M Federal Grant to Accelerate Development of Infection Prevention Medical Device
Lindo has secured $2 million in matched funding through the Australian Government’s Industry Growth Program to advance the development of the Lindo Tube, an endotracheal tube embedded with antimicrobial blue light (aBL)...
Lindo Welcomes Michael Datta to the Advisory Board
Lindo is delighted to welcome Michael Datta, Founder, Board Director, and Strategic Advisor at Noosa Partners, to our Advisory Board. Michael will work closely with Lindo as the company continues to scale. He brings extensive experience in global brand building,...
Deepening Ties: Lindo & Spectral Blue by LED Tailor Strengthen Strategic Collaboration
Salo, Finland – June 2025 — Lindo is pleased to announce the signing of a new distribution and licensing agreement with Spectral Blue by LED Tailor, marking an important step forward in the partnership between the two companies. The agreement was formalised last week...
Lindo Wins 2024 Outstanding Start-Up Award for Life-Saving Medical Innovation
Lindo has been named Outstanding Start-Up at the 2024 Endeavour Awards, Australia’s premier manufacturing industry event, for its breakthrough medical device, Lindo Tube. Developed with the Mayo Clinic, Lindo Tube integrates antimicrobial blue light (aBL) into an...
Lindo Life Science Signs Know-How License Agreement with Mayo Clinic
September 2024 – Jacksonville, US - Lindo Life Science, a division of Lindo Technology Group, is proud to announce the establishment of a know-how license agreement with Mayo Clinic. This collaboration aims to develop a groundbreaking endotracheal tube embedded with...
Lindo Wins 2023 Safety Solution of the Year for Innovative Disinfection Technology
Lindo has been awarded Safety Solution of the Year at the 2023 Endeavour Awards, Australia’s premier manufacturing industry event, recognising its pioneering work in safe, automated antimicrobial blue light (aBL) disinfection systems. The award was presented for Lindo...